FMP
Nexien BioPharma, Inc.
NXEN
PNK
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
0.02025 USD
-0.0006 (-2.96%)
About
ceo
Mr. Richard S. Greenberg
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.nexienbiopharma.com
exchange
PNK
Description
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
CIK
0001625288
ISIN
US65343D1000
CUSIP
65343D100
Address
4340 East Kentucky Avenue
Phone
303 495 7583
Country
US
Employee
N/A
IPO Date
Nov 29, 2017
Summary
CIK
0001625288
Exchange
PNK
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
65343D100
ISIN
US65343D1000
Country
US
Price
0.02
Beta
1.66
Volume Avg.
11.05k
Market Cap
1.37M
Shares
-
52-Week
0.011-0.1
DCF
-0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.02
P/B
-
Website
https://www.nexienbiopharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NXEN News
It looks like there's no news available.
